|
1
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yuen PW, Lam KY, Chan AC, Wei WI and Lam
LK: Clinicopathological analysis of local spread of carcinoma of
the tongue. Am J Surg. 175:242–244. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Po Wing Yuen A, Lam KY, Lam LK, Ho CM,
Wong A, Chow TL, Yuen WF and Wei WI: Prognostic factors of
clinically stage I and II oral tongue carcinoma-A comparative study
of stage, thickness, shape, growth pattern, invasive front
malignancy grading, Martinez-Gimeno score and pathologic features.
Head Neck. 24:513–520. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thai TH, Calado DP, Casola S, Ansel KM,
Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, et
al: Regulation of the germinal center response by microRNA-155.
Science. 316:604–608. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brennecke J, Hipfner DR, Stark A, Russell
RB and Cohen SM: Bantam encodes a developmentally regulated
microRNA that controls cell proliferation and regulates the
proapoptotic gene hid in Drosophila. Cell. 113:25–36. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P
and Stoffel M: A pancreatic islet-specific microRNA regulates
insulin secretion. Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Holland H, Koschny T, Ahnert P,
Meixensberger J and Koschny R: WHO grade-specific comparative
genomic hybridization pattern of astrocytoma-a meta-analysis.
Pathol Res Pract. 206:663–668. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Segura MF, Hanniford D, Menendez S, Reavie
L, Zou X, AlvarezDiaz S, Zakrzewski J, Blochin E, Rose A, Bogunovic
D, et al: Aberrant miR-182 expression promotes melanoma metastasis
by repressing FOXO3 and microphthalmia-associated transcription
factor. Proc Natl Acad Sci USA. 106:1814–1819. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lowery AJ, Miller N, Dwyer RM and Kerin
MJ: Dysregulated miR-183 inhibits migration in breast cancer cells.
BMC Cancer. 10:5022010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu S, Lu Z, Liu C, Meng Y, Ma Y, Zhao W,
Liu J, Yu J and Chen J: miRNA-96 suppresses KRAS and functions as a
tumor suppressor gene in pancreatic cancer. Cancer Res.
70:6015–6025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu B, Mu Y, Cao C, Zeng F, Schneider S,
Tan J, Price J, Chen J, Freeman M and Hallahan DE: Survivin as a
therapeutic target for radiation sensitization in lung cancer.
Cancer Res. 64:2840–2845. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kawasaki H, Toyoda M, Shinohara H, Okuda
J, Watanabe I, Yamamoto T, Tanaka K, Tenjo T and Tanigawa N:
Expression of survivin correlates with apoptosis, proliferation and
angiogenesis during human colorectal tumorigenesis. Cancer.
91:2026–2032. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fan LF, Dong WG, Jiang CQ, Qian Q and Yu
QF: Role of Hypoxia-inducible factor-1 alpha and Survivin in
colorectal carcinoma progression. Int J Colorectal Dis.
23:1057–1064. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nassar A, Sexton D, Cotsonis G and Cohen
C: Survivin expression in breast carcinoma: Correlation with
apoptosis and prognosis. Appl Immunohistochem Mol Morphol.
16:221–226. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu L, Zhang M and Zou P: Expression of
PLK1 and survivin in diffuse large B-cell lymphoma. Leuk Lymphoma.
48:2179–2183. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shu M, Zheng X, Wu S, Lu H, Leng T, Zhu W,
Zhou Y, Ou Y, Lin X, Lin Y, et al: Targeting oncogenic miR-335
inhibits growth and invasion of malignant astrocytoma cells. Mol
Cancer. 10:592011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang S, Kim K, Jin UH, Pfent C, Cao H,
Amendt B, Liu X, WilsonRobles H and Safe S: Aryl hydrocarbon
receptor agonists induce microRNA-335 expression and inhibit lung
metastasis of estrogen receptor negative breast cancer cells. Mol
Cancer Ther. 11:108–118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang
X, Jiang L, Sun Z, Miao Z and Xu H: MicroRNA-335 acts as a
metastasis suppressor in gastric cancer by targeting Bcl-w and
specificity protein 1. Oncogene. 31:1398–1407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shen Z, Zhan G, Ye D, Ren Y, Cheng L, Wu Z
and Guo J: MicroRNA-34a affects the occurrence of laryngeal
squamous cell carcinoma by targeting the antiapoptotic gene
survivin. Med Oncol. 29:2473–2480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ventura A and Jacks T: MicroRNAs and
cancer: Short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu ZF, Liang ZQ, Li L, Zhou YB, Wang ZB,
Gu WF, Tu LY and Zhao J: MiR-335 functions as a tumor suppressor
and regulates survivin expression in osteosarcoma. Eur Rev Med
Pharmacol Sci. 20:1251–1257. 2016.PubMed/NCBI
|
|
26
|
Lu Y, Yang H, Yuan L, Liu G, Zhang C, Hong
M, Liu Y, Zhou M, Chen F and Li X: Overexpression of miR-335
confers cell proliferation and tumour growth to colorectal
carcinoma cells. Mol Cell Biochem. 412:235–245. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun J, Ji J, Huo G, Song Q and Zhang X:
miR-182 induces cervical cancer cell apoptosis through inhibiting
the expression of DNMT3a. Int J Clin Exp Pathol. 8:4755–4763.
2015.PubMed/NCBI
|
|
28
|
Wallis CJ, Gordanpour A, Bendavid JS,
Sugar L, Nam RK and Seth A: MiR-182 Is associated with growth,
migration and invasion in prostate cancer via suppression of FOXO1.
J Cancer. 6:1295–1305. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Marsh EE, Lin Z, Yin P, Milad M,
Chakravarti D and Bulun SE: Differential expression of microRNA
species in human uterine leiomyoma versus normal myometrium. Fertil
Steril. 89:1771–1776. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ronchetti D, Lionetti M, Mosca L, Agnelli
L, Andronache A, Fabris S, Deliliers GL and Neri A: An integrative
genomic approach reveals coordinated expression of intronic
miR-335, miR-342 and miR-561 with deregulated host genes in
multiple myeloma. BMC Med Genomics. 1:372008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Uziel T, Karginov FV, Xie S, Parker JS,
Wang YD, Gajjar A, He L, Ellison D, Gilbertson RJ, Hannon G and
Roussel MF: The miR-17~92 cluster collaborates with the Sonic
Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci USA.
106:2812–2817. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen
XM and Gao HJ: Initial study of microRNA expression profiles of
colonic cancer without lymph node metastasis. J Dig Dis. 11:50–54.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Scarola M, Schoeftner S, Schneider C and
Benetti R: miR-335 directly targets Rb1 (pRb/p105) in a proximal
connection to p53-dependent stress response. Cancer Res.
70:6925–6933. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tavazoie SF, Alarcón C, Oskarsson T, Padua
D, Wang Q, Bos PD, Gerald WL and Massagué J: Endogenous human
microRNAs that suppress breast cancer metastasis. Nature.
451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu W, Zhou K, Zha Y, Chen D, He J, Ma H,
Liu X, Le H and Zhang Y: Diagnostic Value of Serum miR-182,
miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage
Non-Small Cell Lung Cancer. PLoS One. 11:e01530462016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jin ZB, Hirokawa G, Gui L, Takahashi R,
Osakada F, Hiura Y, Takahashi M, Yasuhara O and Iwai N: Targeted
deletion of miR-182, an abundant retinal microRNA. Mol Vis.
15:523–533. 2009.PubMed/NCBI
|
|
37
|
Yan D, Dong XD, Chen X, Yao S, Wang L,
Wang J, Wang C, Hu DN, Qu J and Tu L: Role of microRNA-182 in
posterior uveal melanoma: Regulation of tumor development through
MITF, BCL2 and cyclin D2. PLoS One. 7:e409672012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun Y, Fang R, Li C, Li L, Li F, Ye X and
Chen H: Hsa-mir-182 suppresses lung tumorigenesis through down
regulation of RGS17 expression in vitro. Biochem Biophys Res
Commun. 396:501–507. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kong WQ, Bai R, Liu T, Cai CL, Liu M, Li X
and Tang H: MicroRNA-182 targets cAMP-responsive element-binding
protein 1 and suppresses cell growth in human gastric
adenocarcinoma. FEBS J. 279:1252–1260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yi R, Li Y, Wang FL, Miao G, Qi RM and
Zhao YY: MicroRNAs as diagnostic and prognostic biomarkers in
colorectal cancer. World J Gastrointest Oncol. 8:330–340.
2016.PubMed/NCBI
|
|
41
|
Li F and Brattain MG: Role of the survivin
gene in pathophysiology. Am J Pathol. 169:1–11. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Altieri DC: Survivin, cancer networks and
pathway-directed drug discovery. Nat Rev Cancer. 8:61–70. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li F and Altieri DC: The cancer
antiapoptosis mouse survivin gene: Characterization of locus and
transcriptional requirements of basal and cell cycle-dependent
expression. Cancer Res. 59:3143–3151. 1999.PubMed/NCBI
|
|
44
|
Ito T, Shiraki K, Sugimoto K, Yamanaka T,
Fujikawa K, Ito M, Takase K, Moriyama M, Kawano H, Hayashida M, et
al: Survivin promotes cell proliferation in human hepatocellular
carcinoma. Hepatology. 31:1080–1085. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang R, Wang T, Li KN, Qin WW, Chen R,
Wang K, Jia LT, Zhao J, Wen WH, Meng YL, et al: A survivin double
point mutant has potent inhibitory effect on the growth of
hepatocellular cancer cells. Cancer Biol Ther. 7:547–554. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xu Y, Fang F, Ludewig G, Jones G and Jones
D: A mutation found in the promoter region of the human survivin
gene is correlated to overexpression of survivin in cancer cells.
DNA Cell Biol. 23:527–537. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jang JS, Kim KM, Kang KH, Choi JE, Lee WK,
Kim CH, Kang YM, Kam S, Kim IS, Jun JE, et al: Polymorphisms in the
survivin gene and the risk of lung cancer. Lung Cancer. 60:31–39.
2008. View Article : Google Scholar : PubMed/NCBI
|
